What's the real ROI of adding an AI voice agent to Close CRM?

800,000 calls sounds impressive until you ask how many of them turned into a closed deal. That's the number nobody puts in the press release.

Call volume is easy to measure and easy to be impressed by. It's also almost meaningless on its own. If you're deciding whether Chloe is worth it, you need a different set of numbers — the ones that actually connect to revenue, and the ones you'll actually be able to defend in a board meeting or a partner conversation without someone immediately asking a harder follow-up question.

This is where a lot of AI tooling ROI conversations go wrong generally, not just with Chloe specifically. Activity metrics are the easiest to produce and the least connected to whether the money you're spending is actually paying you back in any way that matters to the business.

What should you actually be measuring?

Speed to first contact. Meetings booked per hundred leads. Show rate on those meetings. Pipeline generated from leads that would've otherwise gone untouched entirely. Every one of these ties back to money in a way that's easy to trace. Calls made doesn't, no matter how large the number gets over time.

What's the honest cost side of the equation?

Usage-based AI pricing on top of your Close plan, plus the time it takes to build and refine the script in the first place. That's a real cost, but it's small compared to a headcount hire, which is exactly the comparison you should be running, not a lazy comparison of free tool versus doing nothing at all.

Where does ROI actually show up first?

Almost always in re-engagement — the leads sitting cold in your CRM that a human was never going to get back to on their own. Even a modest reactivation rate on a pile of dead leads is pipeline you weren't going to get otherwise. That's where the math is easiest to prove, because the baseline for comparison is literally zero.

How do you build the actual before-and-after comparison?

Pull your speed-to-lead and meeting-booked rates from the month before Chloe went live. Compare them to the same metrics a month after, using the exact same lead source if possible. That side-by-side is the number that actually settles the ROI question — not a beta case study from a different company entirely, with a different offer, a different lead pool, and a different starting point.

Keep the comparison narrow at first. Look at one segment, before and after, rather than trying to attribute your whole pipeline's performance to one new tool that only touched a fraction of it. A clean, narrow comparison is far more convincing than a broad one that's hard to isolate from everything else that changed that same month.

What's a realistic range of outcomes to expect?

Results vary widely by industry, offer, and how clean the underlying CRM was before Chloe arrived on the scene. Rather than anchoring on someone else's number from a press release, run your own pilot on a defined segment for thirty to sixty days and let that segment's actual numbers set your expectations for the next one you roll out.

How long before you actually know if it's working?

Give it a full sales cycle, not a week. Call volume shows up immediately, on day one. Booked meetings take longer to accumulate. Closed revenue takes longer still, sometimes months depending on your typical deal cycle. Measure the whole chain before you decide anything, not just the part that happens fastest and looks good early.

Want to know your real numbers, not just call counts?

We set up the reporting that actually tracks Chloe's ROI — meetings, pipeline, and closed revenue, not just activity. Know what it's worth before you scale it.

Book a call with RevPilot →

‍